Страница клинических исследований Nct
Clinical Trial Results:
A three-month, double-blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 µg twice daily of Formoterol-HFA and 12 µg twice daily of Formoterol-DPI (Foradil/Aerolizer) in children with persistent asthma
| Summary | |
EudraCT number | 2004-000755-41 |
Trial protocol | CZ |
Global completion date | 06 Jun 2005 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 06 Jan 2017 |
First version publication date | 06 Jan 2017 |
Other versions | |
Summary report(s) | EudraCT No. 2004-000755-41 ICH E3 Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.